Bodes well for CVac...
Avastin approved with median PFS benefit of 3.3 months and known side effects.
Treatment cost of $100,000 in the US (lung)
"The median time of progression free survival was 6.7 months in the combination therapy group, compared to 3.4 months in chemotherapy alone group."
-http://www.medindia.net/news/chemotherapy-avastin-combination-boosts-progression-free-survival-time-in-ovarian-cancer-patients-102169-1.htm
Known side effects:
http://www.drugs.com/sfx/avastin-side-effects.html
Just goes to show how important any benefit is for an unmet need.
Bodes well for CVac...Avastin approved with median PFS benefit...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |